PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

PAR CEO explains SAS patient results in interview, page-28

  1. 1,722 Posts.
    lightbulb Created with Sketch. 3374
    I think we're definitely flying under the radar. I subscribe to plenty of ASX investing channels on Youtube and I've only seen one channel mention PAR, that was a couple of years ago and it was fairly dismissive. For example, certainly nowhere near the amount of attention MSB has received. Strange, because PAR has had some decent MSM coverage with Andrew Walker's recovery etc. and has a compelling story with results to back it up.

    Current sp doesn't really matter to me, but the lack of attention is something I have noticed.
    Last edited by Gvan: 08/02/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.